Table 4.
Characteristics of individuals with parallel IgG EIA results indicating HEV-C1 exposure.
| Patient | Age | Sex | Ethnicity | Underlying conditions | HEV-C1 p241 OD value | A/C ratio∗ | Documented unexplained hepatitis |
|---|---|---|---|---|---|---|---|
| 1 | 30 | M | Chinese | Renal transplant | 1.531 | N/A | No |
| 2 | 59 | M | Chinese | Renal transplant | 2.225 | N/A | No |
| 3 | 50 | M | South Asian | Liver transplant | 1.338 | 1.433 | No |
| 4 | 70 | M | Chinese | Heart transplant | 2.711 | 1.063 | Yes |
| 5 | 75 | M | Chinese | Liver transplant | 0.967 | 0.478 | Yes |
| 6 | 40 | F | Chinese | Liver transplant | 1.928 | 1.585 | No |
| 7 | 73 | M | Chinese | Heart transplant | 1.290 | 1.290 | Yes |
| 8 | 62 | M | Chinese | Diabetes, HBV carrier | 0.988 | 1.278 | No |
| 9 | 70 | F | Chinese | Diabetes, HBV carrier | 1.719 | 1.426 | Yes† |
| 10 | 74 | M | Chinese | Hypertension | 1.500 | 1.183 | Yes |
| 11 | 61 | M | Chinese | HBV carrier | 0.925 | 0.692 | No |
EIA, enzymatic immunoassay; HBV, hepatitis B virus; HEV-C1, Rocahepevirus ratti; N/A, not applicable; OD, optical density.
A/C ratio = ODHEV-A4 p239/ODHEV-C1 p241 only applied when samples are positive in both EIAs.
Transient alanine aminotransferase elevation when HBV was suppressed with entecavir.